High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

PURPOSE: In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanfang, Su, Wenjia, Liang, Guohua, Shan, Xiaoyu, Ma, Weiwei, Tang, Dabei, Li, Liru, Niu, Xingjian, Zhao, Shu, Zhang, Qingyuan, Zhao, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543895/
https://www.ncbi.nlm.nih.gov/pubmed/34696815
http://dx.doi.org/10.1186/s40360-021-00529-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543895/
https://www.ncbi.nlm.nih.gov/pubmed/34696815
http://dx.doi.org/10.1186/s40360-021-00529-3

Ejemplares similares